Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bdee2e9d086291bae1932745e34bc2d1d> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bdee2e9d086291bae1932745e34bc2d1d NCIT_P378 "NCI" @default.
- Bdee2e9d086291bae1932745e34bc2d1d type Axiom @default.
- Bdee2e9d086291bae1932745e34bc2d1d annotatedProperty IAO_0000115 @default.
- Bdee2e9d086291bae1932745e34bc2d1d annotatedSource NCIT_C148145 @default.
- Bdee2e9d086291bae1932745e34bc2d1d annotatedTarget "A radioconjugate composed of PSMA-617, a human prostate-specific membrane antigen (PSMA)-targeting ligand, conjugated to the beta-emitting radioisotope lutetium Lu 177 (177Lu), with potential antineoplastic activity against PSMA-expressing tumor cells. Upon intravenous administration of lutetium Lu 177 vipivotide tetraxetan, vipivotide tetraxetan targets and binds to PSMA-expressing tumor cells. Upon binding, PSMA-expressing tumor cells are destroyed by 177Lu through the specific delivery of beta particle radiation. PSMA, a tumor-associated antigen and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells." @default.